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During respiration, particles suspended in the air are inhaled and unless cleared
by airway defences they can remain and affect lung health. Their size precludes
the use of standard imaging modalities so we have developed synchrotron
phase-contrast X-ray imaging (PCXI) methods to non-invasively monitor the
behaviour of individual particles in live mouse airways. In this study we used
these techniques to examine post-deposition particle behaviour in the trachea.
PCXI was used to monitor the deposition and subsequent behaviour of particles
of quarry dust and lead ore; ﬁbres of asbestos and ﬁbreglass; and hollow glass
micro-spheres. Visibility was examined in vitro and ex vivo to avoid the
complicating effects of surrounding tissue and respiratory or cardiac motion.
Particle behaviour was then examined after deposition onto the tracheal airway
surfaces of live mice. Each particle and ﬁbre looked and behaved differently on
the airway surface. Particles lodged on the airway shortly after deposition, and
the rate at which this occurred was dependent on the particle type and size.
After the live-imaging experiments, excised airway samples were examined
using light and electron microscopy. Evidence of particle capture into the airway
surface ﬂuids and the epithelial cell layer was found. PCXI is a valuable tool for
examining post-deposition particulate behaviour in the tracheal airway. These
ﬁrst indications that the interaction between airways and individual particles
may depend on the particle type and size should provide a novel approach to
studying the early effects of respired particles on airway health.
Keywords: particles; pollution; airway surface; lung; trachea; mucociliary transit;
non-invasive; X-ray imaging; mouse.
1. Introduction and objectives
Air pollution is a signiﬁcant environmental and health
concern. Man-made airborne pollutants from a wide variety of
sources are suspended in the air in liquid, gaseous or solid
forms. We have previously described a new technique to image
solid particulates and ﬁbres such as quarry dust, ﬁbreglass,
asbestos and lead in mouse nasal airways (Donnelley et al.,
2009). These pollutants have the potential to produce dele-
terious acute or delayed health effects, and can impact on
asthma, cystic ﬁbrosis (CF), bronchitis, emphysema, respira-
tory allergies and heart disease (O’Connor et al., 2008). For
example, CF patients living in regions with high particulate
matter air pollution, such as in metropolitan areas, have
decreased lung function as well as an increased risk of
pulmonary exacerbations (Goss et al., 2004). Particulate
pollution can affect young children more severely than adults,
owing to their different lung size and physiology, breathing
patterns and rapid development (Wildhaber, 2006). The
manner in which particulates deposit onto the airway surface
and their behaviour after deposition are poorly understood
but are likely to inﬂuence or predict key aspects of their
subsequent pathophysiology.
Mucociliary transit (MCT) function is one measure of the
likely effectiveness by which the airways clear inhaled pollu-
tant particles and is a diagnostic indicator of airway health. To
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help determine the effectiveness of genetic (Stocker et al.,
2009; Limberis et al., 2002) and other potential therapeutics for
CF airway disease we have developed novel MCT monitoring
methods, based on measuring the transit rate of individual
deposited particles, that can be used in vivo in mice. Existing
methods for quantifying bulk particle clearance in airways
(Grubb et al., 2004; Donaldson et al., 2007; Livraghi & Randell,
2007) are unable to non-invasively detect and track the motion
of individual pollutant particles in real time and with high
resolution. Direct non-invasive visualization of the behaviour
of deposited particles in animal-model airways is expected to
improve our understanding of airway surface function and
suggest novel methods for prevention or treatment of
respiratory disease in both young children and adults.
This study utilized synchrotron phase-contrast X-ray
imaging (PCXI) to detect, monitor and compare the deposi-
tion and transit behaviour of selected pollutant particles in the
tracheal airway in live mice. PCXI provides enhanced image
contrast by utilizing X-ray refraction in addition to conven-
tional absorption and is particularly useful for achieving soft
tissue contrast where the absorption differences are small.
Tissue boundaries are enhanced by the phase changes induced
by differences in their X-ray refractive indices, provided the
X-ray beam has sufﬁcient spatial coherence and the sample-
to-detector distance is sufﬁciently long (Snigirev et al., 1995;
Cloetens et al., 1996; Wilkins et al., 1996), characteristics that
are achievable using a synchrotron source. We have demon-
strated the use of PCXI for novel non-invasive airspace
imaging in small animals (Parsons et al., 2008), and for non-
invasive particulate detection in live mouse nasal airways
(Donnelley et al., 2009; Siu et al., 2008). Since deleterious
respiratory health effects are predominantly lung-based, the
objective of the current study was to establish PCXI techni-
ques to examine particulate deposition and transit behaviour
in live mouse trachea. Using commonly inhaled pollutants
delivered within a saline carrier we sought to document
particle and ﬁbre visibility, post-deposition behaviour on the
tracheal airway surface, transit rates, differences between
particle and ﬁbre types, histological effects and radiation dose.
We also aimed to determine whether the anatomical and
physiological differences between the nasal and tracheal
airways resulted in different post-deposition behaviour to that
which we previously recorded in the mouse nose.
2. Methods
Experiments were performed on the BL20XU undulator
beamline at the SPring-8 synchrotron radiation facility in
Japan, under approvals from the Animal Ethics Committee of
SPring-8, and of the Children, Youth and Women’s Health
Service, Adelaide. The imaging hutch was located in the
Biomedical Imaging Centre, 245 m from the storage ring, and
the imaging layout (see Fig. 1) was as shown previously
(Parsons et al., 2008). Monochromatic 25 keV ( = 0.5 A˚) X-
rays were selected using a standard double-crystal mono-
chromator (Yabashi et al., 1999). At the imaging station the
beam size was approximately 4 mm (H)  2 mm (V). A
propagation (sample-to-detector) distance of 135 cm was
chosen to produce a sufﬁciently strong bright/dark fringe from
the boundary of each particle, so that they could be identiﬁed
amid intensity variations introduced by overlying tissue and
skin. Images were captured using a high-resolution X-ray
converter (AA50 Hamamatsu Photonics) with a charge-
coupled device (CCD) detector. The converter used a 10 mm-
thick scintillator (Lu2SiO5:Ce) to convert X-rays to visible
light, which was then directed to the CCD using a 20
microscope objective lens with a numerical aperture of 0.4.
The CCD detector was a pco.4000 (PCO Imaging) with an
array size of 4008  2672 pixels and a 9 mm  9 mm native
pixel size. This set-up resulted in an effective isotropic pixel
size of 0.45 mm and a ﬁeld of view of 1.8 mm  1.2 mm. The
beam was limited to approximately this size using slits where
the beam enters the experimental hutch to reduce the radia-
tion dose to the animals. The FWHM of the point spread
function, as determined from a horizontal edge image, was
measured at 3.6 mm. A fast shutter (Uniblitz XRS6 with
VMM-T1 timer unit) received triggers from the ventilator
(refer to the in vivo study description below) to control image
capture to minimize the dose between exposures. Exposure
times of 100 ms, 180 ms and 280 ms were used for the in vitro,
ex vivo and in vivo studies, respectively. These exposure
lengths produced the optimum images, capturing sufﬁcient
incident photons to ﬁll the potential dynamic range (214 grey
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Figure 1
The in vivo imaging set-up in the BL20XU imaging hutch with the
approximate path of the X-ray beam shown in yellow. A diagram of the
set-up was shown previously by Parsons et al. (2008). The X-ray beam
passed through a shutter, ion chamber and the mouse trachea before
reaching the X-ray converter and camera. The propagation distance
between the mouse and X-ray converter was 135 cm. The hand of a
researcher is visible on the right, preparing to deliver a particulate sample
to the mouse trachea.
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levels) of the detector, providing the maximal signal-to-noise
ratio without inducing detector saturation.
2.1. In vitro studies
In this experiment the same ﬁve raw pollutant samples
previously tested in the mouse nasal airway (Donnelley et al.,
2009) were examined in vitro to verify the particle visibility
under PCXI, the particle size distribution, and to determine
a suitable concentration for in vivo testing in the trachea.
Chrysotile (white asbestos), provided by the South Australian
Museum, was manually ground under water and allowed to
settle to produce ﬁbre fractions suitable for examination.
Fibreglass from a commercial pipe insulation, and galena, the
natural mineral form of lead sulﬁde (PbS) in lead ore, from the
South Australian Museum, were both ﬁnely ground using a
mortar and pestle. Dolomite quarry dust that settled out of
airborne suspension was provided courtesy of the Boral
Resources (SA) Limited Linwood Quarry (Adelaide, South
Australia). Hollow silver-coated glass beads with a median
diameter of 14 mm were obtained from Potter Industries
(Melbourne, Australia) for use as reference particles of known
composition, shape and size.
For the in vitro study raw samples were prepared in
physiological saline at concentrations of 0.1% w/v and 1% w/v,
and 15 ml samples were pipetted inside small steel washers
(7/32" inside diameter) pressed onto the adhesive surface of
Kapton tape, a polyimide ﬁlm highly transparent to X-rays
(Argon Masking, PC500, 25 mm thick with 38 mm-thick
silicon adhesive). The washers containing the samples were
then sealed using a second piece of tape (test samples are
shown in Fig. 2f) and mounted for imaging within the imaging
hutch on a motorized sample stage with x and y translation (in
a plane perpendicular to the beam direction).
The in vivo PCXI images of the pollutants were analysed
using Matlab (version 7.9.0 R2009b, The MathWorks) to
determine their size distribution. Images were automatically
adjusted using adaptive histogram equalization, a threshold
applied to binarize the image, and a connectivity analysis
performed to identify unique objects. The effective diameter
of the particles as well as the length and width of the ﬁbres
were then calculated using the known effective pixel resolu-
tion of the image to produce a distribution histogram. Only
objects with a size greater than 4 mm were included because
smaller fragments could not be accurately separated by this
analysis.
2.2. Ex vivo studies
A pilot ex vivo experiment was performed using one
HOS:HR-1 mouse humanely killed by Nembutal overdose
(325 mg kg1 i.p.). The trachea was excised and placed into
a sealed and humidiﬁed study chamber with Kapton ﬁlm
windows to minimize specimen dehydration during the
experiment. The chamber held the excised trachea vertically
with each end cannulated with 20 Ga i.v. catheters (Insyte,
Becton Dickinson, Utah, USA). The chamber was mounted on
the sample stage in the imaging hutch such that the X-ray
beam passed laterally through the excised trachea in the same
orientation used in subsequent in vivo studies. Images were
captured at baseline and after delivery of 15 ml bolus samples
of the particulates suspended in 0.9% saline. After treatment
the sample chamber was also translated vertically to allow the
full length of the excised trachea to be imaged using a number
of exposures (see Fig. 4a).
2.3. In vivo studies
In vivo experiments were performed using 15 hairless
HOS:HR-1 mice weighing 18–26 g. This hairless strain,
commonly used for dermatological experiments in Japan, was
chosen to eliminate interference from fur in the high-resolu-
tion PCXI images. Mice were anaesthetized with Nembutal
(72 mg kg1, i.p.) and the imaging area around the trachea
was cleared of residual fur using depilatory cream (Nair,
Church & Dwight, Australia). The mice were then intubated
using an arterial guide wire and a 20 Ga i.v. catheter as an
endotracheal (ET) tube (Hamacher et al., 2008). The ET tube
was inserted into the trachea to a ﬁxed depth of 22.5 mm from
the nose tip to avoid physical perturbation of the more distal
imaging region. The catheter needle-hub was immediately cut
off to minimize respiratory dead-space, and so that the ET
tube was ready for connection to the ventilator circuit. Mice
were secured to a polyethylene imaging board with their
dorsal incisors hooked over a stainless-steel wire loop and the
limbs, shoulders and torso taped to the board to minimize
body movements that interfere with high-resolution imaging.
The imaging board was mounted on the hutch sample stage
such that the X-ray beam passed laterally through the mouse
trachea, at approximately three cartilage rings below the tip of
the ET tube (see Figs. 1 and 4b). The ET tube was connected
to a ﬂexiVent small animal ventilator (Scireq, Canada), and
anaesthesia was maintained using a passively humidiﬁed
isoﬂurane O2 mixture [Fisher and Paykel HC100 respiratory
humidiﬁer and Univentor U400 (Zejtun, Malta) isoﬂurane
vaporiser]. Ventilation was set at 80 breaths per minute, a tidal
volume of 20 ml kg1 (minute ventilation of approximately
1.6 ml g1), and 3 cm H2O of PEEP. The almost continuous
motion present during normal breathing provides a technically
challenging experimental setting so the ventilatory proﬁle was
conﬁgured with Tinspiration = 0.1875 s, Tpause = 0.3125 s and
Texpiration = 0.25 s, providing a sufﬁcient end-inspiratory pause
to allow relatively motion-artefact-free image capture.
Groups of three mice were exposed to each of the ﬁve
particulates. Image capture was triggered by the ventilator
once every 14 breaths (10.5 s). After 3.5 min of baseline
collection (20 images) a 15 ml sample of the particulate
suspended in saline was manually delivered in a single bolus
over 10 s via the ET tube using a 25 ml glass syringe. This
involved opening the hutch door, manually disconnecting and
reconnecting the ET tube from the ventilator and closing the
hutch door, producing a delay of typically 1 min between
particulate delivery and imaging. Image acquisition was
resumed at the same rate for a further 42 min (240 images),
creating a dataset consisting of 260 images per mouse. Since
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these mice were not allowed to recover after completion of the
experiment we did not attempt to minimize the delivered
radiation dose (beyond using slits to reduce the beam size and
a fast shutter to minimize exposure to the beam); rather, we
maximized both the number and quality of the images
acquired to ensure the best possible experimental results.
2.4. Post-experimental analyses
Mice were humanely killed via Nembutal overdose without
loss of anaesthesia. In some animals the trachea was excised
and ﬁxed for at least 1 h in a non-aqueous ﬁxative (perﬂuoro-
carbon FC-72, 3M Corporation, containing 1% osmium tetr-
oxide, OsO4) to preserve surface ﬂuid, secretions and mucous
in situ for subsequent light and electron microscopy to
determine where particulates lodged after deposition (Sims et
al., 1991). The ﬁxed samples were transferred to 70% ethanol,
embedded in acrylic resin and sectioned for light microscopy
(post-stained with toluidine-blue) and transmission electron
microscopy (post-stained with a saturated solution of 4%
uranyl acetate followed by lead citrate). The elemental
composition of the particulates in the ﬁxed tracheal sections
was also veriﬁed under transmission electron microscopy
(TEM) using energy-dispersive X-ray spectroscopy (EDS)
microanalysis (Philips CM-200) of unstained sections. Control
samples of the raw test particulates were also embedded in
resin to provide EDS reference spectra with which the results
were compared.
The mouse anatomy at the imaging location introduced
confusing detail into the PCXI images since other structures in
the path of the X-ray beam, such as rings of tracheal cartilage,
skin, bone and other tissues, could obscure individual small
particles in single images. To facilitate rapid and accurate
location of relevant particles, each image sequence was ﬂat/
dark-corrected and contrast enhanced (Matlab), and analysed
with simple motion-detection software (VirtualDub, version
1.8.6, Avery Lee, using the MSU Motion Estimation plug-in,
Graphics and Media Lab, Moscow State University) to reveal
where motion was occurring by applying digital image
subtraction and ﬁltering algorithms that identify regions of the
image that change between frames (Donnelley et al., 2009).
For high-quality motion detection the background must
remain still compared with the moving objects to be detected,
hence special efforts were made to minimize the movement
of the mouse during imaging, including the use of restraining
boards and respiratory-gating as described above. Particle
transit rates were calculated by manually tracking the motion
of an individual particle through the image sequence,
measuring the distance it travelled using the known effective
pixel resolution of the image and then dividing by the elapsed
time between the frames.
3. Results
3.1. In vitro studies
The in vitro PCXI visibility of the pollutant particles in
saline was similar to that previously reported for samples
mixed in distilled water (Donnelley et al., 2009). Owing to the
relatively long propagation distance many particles were
visible owing to phase or absorption contrast, or a combina-
tion of both. Fig. 2 shows the results from these in vitro studies,
and clearly demonstrates the differences in appearance
between particle types. The samples were visible both dry and
within saline, indicating that saline had little effect on the
overall contrast. For example, absorption dominated the
image contrast for galena, and produced shadows with few
fringes (Fig. 2d). By comparison, hollow glass beads strongly
refracted the X-rays and produced phase contrast visible as
light and dark fringes; however, no dark shadows were
produced since the beads are very thin walled and hollow
(Fig. 2e). Other particles, such as quarry dust, showed both
phase and absorption contrast, appearing darker where the
object attenuated the beam, as well as displaying bright/dark
fringes around the particle edges (Fig. 2b).
Based on our in vitro observations a concentration of 1%
w/v was selected for the ex vivo and in vivo studies to ensure
sufﬁcient particulates were present in a 15 ml sample to
potentially be visible when deposited into the mouse trachea.
The manual grinding employed during the particulate
preparation was clearly effective as few large particulates were
present, excluding some long asbestos and ﬁbreglass ﬁbres. As
research papers
722 Martin Donnelley et al.  Pollutant particle and fibre deposition J. Synchrotron Rad. (2010). 17, 719–729
Figure 2
PCXI images (1.8 mm  1.2 mm) of 15 ml samples of 1% w/v particulates
suspended in saline used for the in vivo study are shown for (a) asbestos,
(b) quarry dust, (c) ﬁbreglass, (d) galena and (e) silver-coated hollow glass
beads. All images are arranged so that the particulates can be seen wet
and dry. The dry particles are on the top/left, and the particles in saline
are present in the bottom/right. The test sample set-up is shown in ( f );
samples were placed in the centre of small washers that were
encapsulated in Kapton tape.
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previously reported (Donnelley et al., 2009), the asbestos
could not be ﬁnely ground so we relied on differential settling
in water to obtain ﬁner size fractions. The size distribution of
the particles and ﬁbres is shown in Fig. 3, and veriﬁes that
particles typically ranged in diameter from 5 mm up to 12 mm
with a small number of larger particles present. The width of
the ﬁbres was also within this range, but the lengths were
signiﬁcantly greater. Fibreglass ﬁbres of length 40 mm were
not uncommon, but only the asbestos ﬁbres were longer than
50 mm. Despite a stated manufacturers nominal diameter of
14 mm, the majority of the glass beads were smaller.
3.2. Ex-vivo studies
Prior to use in live mice, particle visibility was veriﬁed in a
segment of excised mouse trachea. All particulates were easily
detected and had similar appearances to those observed in
the in vitro study [all particulates are visible in Fig. 4(a)].
Although all particulates were detectable, the quarry dust
particles were more difﬁcult to detect than the ﬁbreglass,
galena and the hollow glass beads. In addition, only one
bundle of asbestos ﬁbres was visible in the trachea in contrast
to the other particulates, of which many individual particles
could be detected. Despite using an enclosed chamber we did
ﬁnd that the excised trachea tended to rapidly and visibly
dehydrate resulting in noticeable shrinkage even over a
10 min imaging period. Since the airway tissue was grossly
affected by this process we did not attempt to use this system
to analyse post-deposition behaviour.
3.3. In vivo studies
3.3.1. Site of particulate delivery in mouse airway. We
found that inserting the ET tube to a depth of 22.5 mm placed
the ET catheter tip two to three cartilage rings below the top
of the trachea (Fig. 4b). In most cases the imaging region was
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Figure 3
Particle and ﬁbre size distribution measured from the in vivo images in Fig. 2.
Figure 4
(a) A montage of nine individual PCXI images from the pilot ex vivo
experiment that examined an excised mouse trachea. The images were
taken after all ﬁve particulates had been delivered within individual 15 ml
boluses. All ﬁve particle types are clearly visible and marked. (b) An
in vivo montage of 15 individual PCXI images with the ET tube
uppermost in the trachea. The ET tube opening is approximately two
cartilage rings from the top, and the standard imaging location, usually
three rings below the bottom of the ET tube, is marked with a white
rectangle. Dark particles of galena are apparent within the ET tube as
well as at the imaging site in the trachea. Image alignment is poor at some
montage frame edges owing to respiratory movements that occurred
between image captures.
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three cartilage rings (1.5–2 mm)
below the end of the ET tube, but in
some mice this was adjusted slightly to
ensure a clear and less obstructed view
of the trachea.
3.3.2. Imaging set-up and particulate
delivery effects. The 15 ml dose
provided sufﬁcient visible ﬂuid and
particulates to be monitored in the
trachea and induced no noticeable
change in respiratory effort or
frequency, as measured by monitoring
the airway pressure recorded by the
ﬂexiVent. In earlier pilot studies higher
doses induced transient coughing that
produced blurred images. We noted that
for the ﬁrst 30 min of the experiment image quality was
excellent, due largely to the respiratory-gating. It is important
to note that the gating only minimized intra-frame motion.
Some inter-frame motion still made isolating particle-motion
difﬁcult, although securely taping the body to the restraint
board minimized this effect. After approximately 30 min most
mice displayed large irregular respiratory excursions initially
every 10 breaths, increasing in frequency and magnitude as
the experiment continued. Mice remained deeply anaes-
thetized as assessed by foot pinch, but these movements
eventually degraded the quality of the images because the
end-inspiratory breath holds became ineffective. Indepen-
dently increasing the level of anaesthesia (e.g. isoﬂurane to
3.5%) as well as the tidal volume (to 25 ml kg1), or using a
single total lung capacity manoeuvre once every 5 min to
ensure complete lung ﬁlling did not alter these complicating
respiratory effects.
One mouse was imaged in a supine position and this almost
eliminated the irregular respiratory movements, suggesting
that the head-high mounting was a likely cause of the
respiratory instability we observed. Consistent with this was
the observation that the tracheal diameter of some mice
reduced over the extended imaging periods, in one case by up
to 0.2 mm. The abdominal contents in some mice also
slumped substantially by the end of the imaging period, and
cartilage rings moved down slowly relative to the X-ray beam,
in some cases by up to 0.2 mm, such that the imaging posi-
tion appeared to change over time.
During these experiments the incident photon ﬂux was
approximately 7.47 109 photons s1, producing an estimated
dose of approximately 0.13 Gy per exposure delivered to the
1.8 mm  1.2 mm imaging area for each of the 280 ms expo-
sures used in vivo.
3.3.3. Appearance and behaviour of particulates in live
mouse trachea. The presence and behaviour of ﬁbreglass,
galena, quarry dust and the hollow silver-coated glass beads
could be detected in vivo, with visibility improved by using
motion-detection software during post-experimental proces-
sing. Of the pollutants that we could detect with PCXI, galena
was the most visible and quarry dust the least visible. Fibre-
glass and the hollow silver-coated glass beads provided inter-
mediate visibility. Despite analysing both the raw and motion-
detected images we did not positively identify asbestos ﬁbres
in any of the image sequences.
Independent of the particle type and size, most particle
deposition and particle motion occurred on the dorsal region
of the trachea. Compared with the number of particulates
detected in the 15 ml in vitro samples (for example galena in
Fig. 2d), few particulates were detected in vivo. Interestingly,
Fig. 4(b) shows that galena particulates remained in the ET
tube after delivery to the trachea. As we did not normally
image at the ET tube site, it is unclear whether this ‘trapping’
of galena particles in the ET tube was a consistent
phenomena.
When particulates were detected they remained visible
throughout the entire imaging period. However, most particle
motion in the trachea occurred within the ﬁrst few minutes of
imaging, with almost all particles lodging by the end of the
imaging period. Small and/or low-density particles continued
their motion for longer than large and/or dense particles; the
latter were observed to lodge quickly on the airway surface.
Almost all galena particulates appeared to be motionless from
the initiation of imaging (1 min after dose delivery), but in
comparison some glass beads continued moving for almost the
entire imaging period. The motion and lodging of quarry dust
and ﬁbreglass were between these two extremes. Quarry dust
appeared as compact and irregularly shaped particles. The
smallest detectable dust particles were approximately 5 mm in
their largest dimension with larger particles up to 20 mm-
diameter present. Most dust particles were approximately
10 mm in diameter. Fig. 5 shows a quarry dust particle moving
along the airway over a period of 2.1 min.1 The transit rate of
this particle (and many others) was not uniform, and varied
between zero and 0.5 mm min1. Dust particles were
particularly difﬁcult to detect when stationary as they were
easily confused with speckled areas of the images, for example
regions of bone, cartilage, connective tissue and skin, although
motion made these particles more easily detectable.
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Figure 5
In vivo imaging of quarry dust in a live mouse trachea. The image on the left was captured
approximately 1.75 min after imaging was started, and the location of a quarry dust particle is
marked with an X. The sequence of image strips to the right (10.5 s apart) were created by cropping
complete image frames as marked, to show the same region in subsequent motion-detected frames.
The motion of the dust particle is tracked by the grey line, and demonstrates variability in the rate of
particle transit for even a single particle. Other particles were also visible when viewed dynamically,
but cannot be seen on these static images. Movie S1 in the online supporting information
(QuarryDust.avi) contains a time-lapse movie of the in vivo behaviour of quarry dust particles.
1 Supplementary data for this paper are available from the IUCr electronic
archives (Reference: MS5027). Services for accessing these data are described
at the back of the journal.
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Most ﬁbreglass ﬁbres were 10 mm to 15 mm in width, and
ranged in length from 30 mm to 80 mm. The relatively long
ﬁbre lengths made ﬁbreglass easier to detect in vivo than the
quarry dust because they were conspicuous against the tissue
background. Small approximately spherical ﬁbreglass particles
10 mm in diameter were also sometimes visible. Fig. 6 shows
one example of stationary ﬁbreglass ﬁbres in the trachea.
Fibres collected predominantly along the dorsal surface of the
trachea, although in this animal a small number of ﬁbres were
also present on the ventral surface.
Galena particles did not move substantially over the
imaging period, but were easily detected in vivo owing to their
strong absorption contrast. Particles generally ranged in size
from 10 mm up to 25 mm, but clusters of galena approximately
60 mm in diameter were present in two mice. Clusters of this
size were not seen in the in vitro study (where galena particles
were typically less than 25 mm in diameter), suggesting that
clustering may have occurred at or after deposition onto the
airway surface. In one animal the galena cluster looped
between two points in the airway rather than staying
stationary; however, this was in contrast to the behaviour of
most large galena particles which tended to lodge quickly on
the airway surface. Fig. 7 shows the behaviour of this large
cluster, with both the transit motion of the galena cluster and
the changes in cluster orientation owing to rotation also
displayed.
The air contained within the hollow glass beads enhanced
their visibility by improving phase contrast, with their sphe-
rical shape producing a lensing effect making them visible as
relatively bright circles. In the airway the beads were readily
visible and varied in size from 10 mm up to 20 mm (despite a
stated manufacturer’s nominal diameter of 14 mm). Fig. 8
shows the motion of multiple glass beads along the dorsal
tracheal surface and, like galena, their particle motion was
not uniform; beads could move in different directions and
at different rates. The transit rate of the marked particles
varied between 0.02 mm min1 distally (toward the lung)
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Figure 8
In vivo imaging of silver-coated hollow glass beads in a live mouse trachea. The image on the left was captured approximately 2 min after imaging was
started. The strips on the right are motion-detected frames 42 s apart from within the marked white rectangle. The motion of four separate particles is
marked: two are moving up the trachea at different speeds, and two are moving more slowly down the trachea. A large number of smaller particles
moved faster than these, but are not clear on these static images. The majority of the glass bead particle transit was located toward the dorsal tracheal
wall. Movie S4 in the online supporting information (GlassBeads.avi) contains a time-lapse movie of the in vivo behaviour of hollow glass beads.
Figure 6
In vivo imaging of ﬁbreglass in a live mouse trachea. (a) The trachea
immediately prior to ﬁbreglass delivery, and (b) the ﬁrst image captured
after imaging began. Although the ﬁbres were visible in the trachea, they
did not move throughout the imaging period. Most ﬁbres were located on
the dorsal tracheal surface but in this animal a small number were also
visible on the ventral surface. Movie S2 in the online supporting
information (Fibreglass.avi) contains a time-lapse movie of the in vivo
behaviour of ﬁbreglass ﬁbres.
Figure 7
In vivo imaging of galena in a live mouse trachea. The image on the left is the ﬁrst image captured after imaging began, and shows a large cluster of lead
particles, as well as smaller individual particles spread throughout the trachea. The strips on the right (10.5 s apart) show the motion of the lead cluster.
The indicator at the top of each strip shows the relative rotation of the cluster. Note that between the ﬁrst and third strips the cluster movement was
brieﬂy retrograde. The majority of the other individual galena particles are located toward the dorsal tracheal wall. Movie S3 in the online supporting
information (Galena.avi) contains a time-lapse movie of the in vivo behaviour of galena particles.
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and 0.37 mm min1 proximally (toward the larynx).
In the same animal (data not shown) we also measured
smaller glass beads moving proximally at more than twice
this rate.
3.3.4. Histological analyses. Histological examination using
light microscopy revealed that all the particulate types except
asbestos were located on or in the airway epithelium. Samples
from mice exposed to quarry dust were inadvertently incor-
rectly processed and could not be examined. Fig. 9 shows the
appearance of the particulates in the trachea under light
microscopy. Galena appeared as dense black particles, ﬁbre-
glass as short green and yellow ﬁbres, and the silver-coated
hollow glass beads had a distinctive round shape with a dark
edge. We did not identify any asbestos ﬁbres in cross sections
from asbestos-treated animals. Particles were located above
the airway surface captured in ﬁne mucus strings (visible only
in TEM images), embedded within the mucus layer adhering
to and overlying the epithelium; and enveloped within the
epithelial cells or the epithelial cell ciliary layer. Galena
particles were often found more deeply in the epithelial layer
than the ﬁbreglass ﬁbres which were typically found at the
epithelial cell/air interface, while the glass beads appeared to
lodge within and partly displace the cilia and surface liquid of
the airway. The spherical glass beads had different apparent
diameters and surface detail depending on the level at which
they were cut, and small fragments of glass and the silver
coating (as veriﬁed by EDS analysis) surrounded all of these
beads.
EDS analysis was used to conﬁrm the elemental composi-
tion of particles present on or in the airway epithelium.
Galena produced spectral peaks that corresponded to
elements including lead and sulfur; ﬁbreglass to sodium,
magnesium, aluminium, silicon and calcium; and the
silver-coated glass beads to silicon and silver. The spectra
of the particulates present in the trachea sections matched
those in the control spectra, conﬁrming the identity of the
particles.
4. Discussion
The primary goal of this study was to establish methods to
deposit a range of common pollutant particles and ﬁbres into
live mouse lung airways to enable monitoring of their post-
deposition behaviour using synchrotron PCXI. Using histo-
logical methods we also sought conﬁrmation of the speciﬁc
location, and elemental identity, of these particles on or within
the cell and surface ﬂuid layers of the airway.
Our in vivo results show the suitability of PCXI tech-
nology for the detection of particles as diverse as quarry
dust, ﬁbreglass, galena and the reference hollow silver-coated
glass beads in an intact animal. To our knowledge this is the
ﬁrst report detailing the non-invasive detection and moni-
toring of the airway surface behaviour of these pollutant
particles in live lung airways. This capability is signiﬁcant
because PCXI has the unique ability to image the initial
deposition, appearance and movement characteristics of
individual pollutant and reference particulates on a live and
intact airway surface. The varieties of individual particle
behaviour (encompassing consistent speed and direction;
stop and start; retrograde movement; changing direction; and
rotation behaviour) reveal the diversity in how the airways
can handle the deposition and transport of particles.
However, the sample size was insufﬁcient to determine
whether the different particle types produced distinct
patterns of airway surface behaviour. Nevertheless, this new
information about the behaviour of individual particles of
potential signiﬁcance in respiratory disease can now
supplement well established methods and data derived from
monitoring bulk transit rates in airways (Grubb et al., 2004)
and can help focus new research into the consequences of
particle deposition from the earliest points of their interac-
tion within the airway.
The ex vivo pilot study demonstrated that the particulates
could easily be detected in an excised trachea with little loss of
the identifying characteristics present in our in vitro studies.
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Figure 9
Examples of galena (G), ﬁbreglass (F) and hollow silver-coated glass
beads (B), captured on the mouse tracheal airway surface. Tissues were
ﬁxed using perﬂuorocarbon OsO4, and semi-thin resin sections cut and
stained with toluidine blue. Panel (b) labels the relevant airway
epithelium structures in a typical cross section; note that not all features
are present on all panels. (a) Galena captured on the surface of the
epithelial cell layer, and (b) smaller particles within the cell cilia (in the
airway surface layer) and embedded in ﬁne mucus strings (not visible
here) above the epithelial cells. (c) The distinctive glass beads are
captured on the airway surface, and (d) one large bead of approximately
55 mm diameter appears displaced into the airway epithelium. (e) Small
ﬁbreglass ﬁbres embedded in the overlying mucus layer.
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We suspect that the visible tissue dehydration was caused by
the dry air within the imaging hutch, and was further exacer-
bated by repeated exposures to the intense X-ray beam. With
ﬂuid bathing, reliable and precise temperature control, heat
dissipation and physiological support we expect that tissue
viability would be maintained and dehydration would be
eliminated. Since this pilot was only intended to examine the
visibility of the tissue and particulates and to demonstrate the
feasibility of performing an ex vivo study, we did not use it to
examine the deposition and clearance behaviour of the test
particulates. Comparison with the in vivo images conﬁrmed
that the tissue surrounding the trachea was the source of
background detail that could obscure some particles in
captured images. The absence of surrounding tissues, as well as
respiratory and cardiac movements, substantially improved
particulate visualization in the ex vivo system, particularly for
those particulates that lodged on the airway surface. We
propose that trials in a functional ex vivo system may provide a
rapid and accurate method to estimate baseline transit rates
prior to testing in vivo, although the absence of reciprocating
airﬂows may alter airway surface clearance behaviour, as ﬂows
are known to affect epithelial cell physiology (Tarran et al.,
2005).
In earlier studies of mouse nasal airways (Donnelley et al.,
2009) we determined that a 15 ml delivered dose was sufﬁcient,
but a particle/ﬁbre concentration of 0.1% w/v used there did
not provide an adequate number of particles to detect and
analyse transit behaviour. Not surprisingly, compared with
that nasal study the ten-fold higher particle concentration (1%
w/v) used here resulted in many more deposited particulates,
although still less than expected based on the in vitro results.
This difference could be explained by the different delivery
set-ups: a pipette for the in vitro study and a long cannula and
glass syringe for the in vivo study. Interestingly, we noted there
were many particulates visible in the ET tube (e.g. Fig. 4b)
suggesting that the effectiveness of the delivery system was
not optimal. The cannula material may have adherent prop-
erties for these particles, so delivery may be improved by using
different cannula materials or surface coatings, altering the
particulate delivery rate, or adjusting the volume and rate of
ET airﬂow. In addition, unlike in the nasal study we did not
detect asbestos ﬁbres in vivo using PCXI, nor in sections
examined under light microscopy or TEM. In bench studies we
have noted that asbestos ﬁbres are prone to clustering and
blockage of ﬁne delivery cannulae, so we speculate that
asbestos was not successfully delivered to the trachea. In
future studies we will reﬁne our techniques and set-up to
ensure correct asbestos delivery.
The behaviour of ﬁbreglass ﬁbres in the trachea differed
from that noted in earlier nasal airway studies (Donnelley et
al., 2009). In the trachea, individual ﬁbreglass ﬁbres were
observed, whilst in the nasal airway study ﬁbres were only
present within a liquid envelope and individual ﬁbres were not
visible. This ﬁnding indicates that particle behaviour may be
determined by the deposition location within the respiratory
system. This may not be surprising, since the nose has evolved
to trap particles after inhalation to prevent their inhalation
into the conducting airways and lungs. We also noted that
particle behaviour in the trachea was determined by both the
type and size of the particles. Smaller and/or low-density
particles tended to move faster and for longer periods, and we
speculate this was because these particles take longer to be
captured on the epithelial surface or in mucus on and above
the surface. Regardless of the type or size of the particles,
individual particle behaviour was often extremely variable.
Thus, while it was possible to visualize individual particle
behaviour, this technique does not measure bulk particle
transit rates. Despite the vertical orientation of the animal the
transit of all particles was consistently localized to the dorsal
tracheal wall.
Histological analysis showed that galena particles and glass
beads could displace cilia and surface liquid and lodge within
the surface of the airway epithelium. Such a behaviour has
been predicted for small particles elsewhere (Gehr & Schurch,
1992) and may be related to the surface tension forces acting
on the particles. This effect may also be independent of the
presence of airway surface mucus. Such a non-speciﬁc process
might help explain why we observed that so many particles
ceased moving soon after delivery.
There were several limitations in this study. Although our
PCXI set-up can resolve particles down to less than 4 mm, the
visual complexity produced by the anatomical structures
surrounding a moving trachea in a live animal means that
particles of approximately 5 mm diameter are currently the
smallest particles we can accurately detect and track. This is
close to the upper size limit for particles that can reach and
deposit in the human trachea after inhalation (Oberdorster et
al., 2005). Despite this limitation, PCXI was demonstrated to
be suitable for examining particulate deposition and post-
deposition behaviour, and with improvements in technology
the visualization of smaller particles will be possible in the
near future.
Both Nembutal (King et al., 1979) and isoﬂurane
(Robertson et al., 2004) have been reported to alter muco-
ciliary transit by affecting mucus rheology and ciliary beat
frequency. Therefore it is likely that the true rate of transit is
faster than the results suggest. However, the ciliary beat
pattern has been shown to be unaffected by isoﬂurane
anaesthesia (Robertson et al., 2004). We are limited by
Japanese Government regulation in the choice of anaesthetics
available for experiments at the SPring-8 synchrotron, but it is
apparent that across the different particle and ﬁbre types, all
delivered under the same anaesthetic regime, there are clear
differences in post-deposition transit behaviour.
This study was also constrained by the inability to enter the
synchrotron imaging hutch during imaging. In these ﬁrst
experiments the ventilator was integrated into the imaging set-
up in a manner that required manual particulate instillations
to be performed. This necessarily introduced a delay while the
beamline hutch door was closed and the X-ray shutter was
opened to begin imaging, so it was not possible to visualize the
actual instillation of the particulates into the mouse airway.
Accordingly, we could not observe the presence and clearance
of the initial bulk-liquid dose, and our ﬁrst live images (albeit
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performed within 1 min of instillation) sometimes revealed
that particles had already lodged on the airway surface. Owing
to this delay it was also impossible to assess whether any
particles in the initial 15 ml bolus were carried directly down
toward the lungs. However, the absence of bulk dose ﬂuid on
the airway surfaces immediately after dosing (when imaging
began) suggests there was a very rapid loss of the dose vehicle,
leaving the pollutants deposited on the airway surface. It also
suggests that delivering the pollutants within a liquid carrier
rather than as dry particles or ﬁbres may have little persistent
effect on the airway environment or the deposition behaviour.
The experimental complexity and the occupational hazards to
researchers when delivering dry or aerosolized pollutant
particles are difﬁcult to handle; however, these studies have
provided encouraging data to support the efforts needed to
safely and effectively test these more physiologically normal
delivery methods in the future.
Owing to image complexity from the mouse anatomy and
motion from respiratory movements we limited the analysis to
the trachea rather than examining the intrapulmonary airways.
In future studies we plan to modify the delivery and imaging
set-up to enable particulate delivery during imaging to capture
the ﬁrst interactions of the pollutants with the airways and to
examine the deeper lung airways where particulate deposition
is also important.
Although we limited the radiation dose by reducing the size
of the imaging area and minimizing the exposure times, at
present the dose delivered using this experimental set-up is
too large to consider animal recovery or repeat-imaging
experimental designs. However, in other experiments we have
found that the exposure times and dose can be reduced by at
least a factor of three by increasing the thickness of the
scintillator and using a higher quality objective lens. In addi-
tion, depending on the experimental aims the number of
exposures can be substantially reduced and image quality may
be traded for further reductions in exposure length and dose.
In addition, the rapid development of imaging and synchro-
tron technologies should also produce improvements in light
sensitivity and image resolution that could allow shorter
exposure times to minimize motion artefact and produce
desired reductions in radiation dose. With these improvements
we expect the dose could realistically be reduced by a factor of
ten compared with that delivered in this experiment. Our goal
remains to progressively improve our maximum resolution,
allowing smaller and therefore more physiologically relevant
particulates to be detected and tracked.
Despite these limitations and challenges there are currently
no alternative in vivo imaging modalities able to non-inva-
sively detect and track such small individual particles or ﬁbre
clusters in the mouse trachea. Thus we propose that PCXI is a
valuable technique for studying the deposition and behaviour
of pollutant particles and ﬁbres in the airways of live animal
models. We also expect that these experimental techniques
will be useful for other synchrotron experiments imaging the
upper lung airways of small animals, and are a practical
addition to the range of related techniques we have estab-
lished for use in mouse nasal airways.
5. Supplementary files
The four supplementary ﬁles contain movie sequences
showing particulate and ﬁbre behaviour on the tracheal airway
surface, and are the source of the images shown in Figs. 5–8.
Each 10 s time-lapse video shows 3.5 min of baseline image
collection (20 images, 10.5 s apart), followed by 14 min of
post-deposition imaging (80 images, 10.5 s apart), and are
presented at 105 normal speed. Between the acquisition of
these two sequences the particulates were manually delivered
into the trachea. All videos are avi ﬁles, were encoded using
the DivX codec and can be played using the free VLC Media
Player (available at http://www.videolan.org/vlc/).
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org/). The synchrotron radiation experiments were performed
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the Japan Synchrotron Radiation Institute (JASRI) under
proposal number 2009A1878. Dr Andreas Fouras, Monash
University Division of Biological Engineering, provided
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onment Manager, Boral Resources (SA) Limited, provided
dolomite quarry dust samples. Ruth-Ellen Williams performed
the histological preparation and assisted with TEM and EDS
at Adelaide Microscopy, and Richard Bright performed the
light microscopy and sample preparation at the Women’s and
Children’s Hospital. KSM was supported by an Australian
Postgraduate Award, a Monash University J. L. William
Scholarship and a Cystic Fibrosis Australia Studentship. MD,
KSM, KKWS and DWP were supported by the AMRF
Program, Commonwealth of Australia.
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